ClinicalTrials.gg
Sign In

Short Bowel Syndrome clinical trials

The registry lists 159 studies for Short Bowel Syndrome across more than 10 countries. 24 are recruiting or about to start. 127 of them are mainly about Short Bowel Syndrome (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-28.

Get an email when these change. Save the Short Bowel Syndrome studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
90
Recruiting
18
Terminated
14
Withdrawn
11
Status unknown
10
Active, not recruiting
6

Phase

Phase 3
35
Phase 2
26
Phase 4
13
Phase 1
11
Early Phase 1
2

Where

United States
80
France
26
Denmark
22
United Kingdom
20
Germany
17
Belgium
16

Who runs them

Shire (15) · Takeda (10) · Boston Children's Hospital (9) · Zealand Pharma (7) · Mayo Clinic (5) · Jinling Hospital, China (5) · VectivBio AG (4) · University of Nebraska (4)

What is being tested here

Drugs under test in Short Bowel Syndrome studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Teduglutide11620
Glepaglutide167
Apraglutide136
Human Growth Hormone114
HM15912101
Amoxicillin101
Levofloxacin101
Ofloxacin101
Fish oil triglycerides035
Fish Oils035

Drug classes tested here GLP-1 receptor agonists 3

Coming up

6phase 3 studies under way
11studies finish main data collection within a year2 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 18 Short Bowel Syndrome studies recruiting now, 8 (44%) set no upper age limit and 8 (44%) stop at 75 or younger. 9 (50%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 2 (11%) take healthy volunteers.

Recruiting studies that take each age, of 18
AgeWomenMen
108 (44%)8 (44%)
1815 (83%)15 (83%)
3012 (67%)12 (67%)
4012 (67%)12 (67%)
5012 (67%)12 (67%)
6512 (67%)12 (67%)
7510 (56%)10 (56%)
8510 (56%)10 (56%)

Across all 159 studies, recruiting or not: 42% stop at 75 or younger and 36% at 65; 48% take children; 0% are for women only and 1% for men only; 13% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Short Bowel Syndrome studies take

Of 27 phase 3 interventional studies under Short Bowel Syndrome, half reached primary completion within 37 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 337 mo24–46 · 27 studies36 mo20–45 · 26 studies—
Interventional, no phase22 mo19–59 · 24 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

Studies

Recruiting first, then most recently updated. Showing 50 of 159. Browse all 159 → or search them.